Doron Lipson BSc, PhD
Bioinformatics, Cell and Developmental Biology, Research and Clinical Research
Cambridge, Massachusetts, United States of America
Connect with the speaker?
Dr. Lipson joined Foundation Medicine in August 2010, bringing more than 10 years of experience in genomic product development and expertise in next-generation sequencing to the company. Dr. Lipson leads the product development efforts and a team that is responsible for computational methods and analytical tools development at Foundation Medicine.
Prior to joining Foundation Medicine, Dr. Lipson developed high-throughput genomic assays at Helicos BioSciences and at Agilent Laboratories. Dr. Lipson was also a co-founder of ProteOptics, which was acquired by Bio-Rad in 2006. Dr. Lipson has a number of publications in a variety of journals including Nature, Science, Nature Medicine, Nature Biotech and PNAS. Dr. Lipson has over 15 accepted and pending patents in the fields of NGS and microarrays.
Prior to joining Foundation Medicine, Dr. Lipson developed high-throughput genomic assays at Helicos BioSciences and at Agilent Laboratories. Dr. Lipson was also a co-founder of ProteOptics, which was acquired by Bio-Rad in 2006. Dr. Lipson has a number of publications in a variety of journals including Nature, Science, Nature Medicine, Nature Biotech and PNAS. Dr. Lipson has over 15 accepted and pending patents in the fields of NGS and microarrays.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com